- Research works
- 28 ▲ 3% vs 2013–17
- Citations
- 325 11.8 per fractional work
- Top-10% rate
- 26.0% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: GL PharmTech (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.6×. Every wedge is a field page.
- Veterinary 9.6×
- Pharmacology, Toxicology and Pharmaceutics 6.7×
- Biochemistry, Genetics and Molecular Biology 5.3×
- Chemical Engineering 4.0×
- Immunology and Microbiology 2.6×
- Chemistry 1.7×
- Medicine 1.7×
- Environmental Science 1.5×
- Earth and Planetary Sciences 1.4×
- Neuroscience 1.2×
- Engineering 0.9×
- Materials Science 0.7×
- Physics and Astronomy 0.4×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Health Professions 0.1×
Which keywords describe research at GL PharmTech (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Biosensors, Nanoparticles, Inflammation, Drug Delivery, Cyclodextrins, Solid Dispersions, Cancer and Gene Expression.
- Reporter Genes
- Electrochemistry
- Solid Dispersions
- Cyclodextrins
- Cancer
- Nanoparticles
- Biosensors
- Inflammation
- Drug Delivery
- Gene Expression
- Bioluminescence
- Oxidative Stress
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 12 words, with their numbers
- Biosensors2▲ 16×5 topics
- Nanoparticles2▲ 6.6×5 topics
- Inflammation2▲ 3.4×18 topics
- Cancer2▲ 3.9×9 topics
- Drug Delivery1▲ 9.8×5 topics
- Cyclodextrins1▲ 187×1 topic
- Gene Expression1▲ 6.8×3 topics
- Solid Dispersions1▲ 187×1 topic
- Bioluminescence1▲ 175×1 topic
- Electrochemistry1▲ 18×2 topics
- Oxidative Stress1▲ 1.98×10 topics
- Reporter Genes1▲ 175×1 topic
Which research topics does GL PharmTech (South Korea) publish most on?
By volume in 2022–2025: Per- and polyfluoroalkyl substances research, Neurofibromatosis and Schwannoma Cases, Advanced biosensing and bioanalysis techniques and Inhalation and Respiratory Drug Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Per- and polyfluoroalkyl substances research Environmental Chemistry 0 works
- 2 Neurofibromatosis and Schwannoma Cases Neurology 0 works
- 3 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 4 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 7 Bacteriophages and microbial interactions Ecology 0 works
- 8 Extracellular vesicles in disease Molecular Biology 0 works
- 9 RNA Interference and Gene Delivery Molecular Biology 0 works
- 10 Gas Sensing Nanomaterials and Sensors Electrical and Electronic Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GL PharmTech (South Korea)'s research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.